|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
48.150 +3.000 (+6.645%) | 2022/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 7,206,440 | 63.532% | 10,290,050 | 5,612,384 | 3,983,687 | 2,534,453 | |
| Cost of Sales | (3,793,233) | 79.781% | (5,461,153) | (3,079,418) | (2,324,858) | (1,516,698) | |
| Gross Profit | 3,413,207 | 48.605% | 4,828,897 | 2,532,966 | 1,658,829 | 1,017,755 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (70,838) | -46.805% | (156,667) | (121,062) | (6,842) | (55,940) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 2,632 | (3,119) | 0 | |
| Profit / (Loss) before Taxation | 2,930,135 | 42.362% | 3,993,119 | 1,965,760 | 1,126,633 | 737,722 | |
| Taxation | (308,910) | 76.067% | (484,538) | (273,066) | (116,296) | (107,257) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (86,161) | 112.021% | (120,103) | (3,808) | 3,468 | 127 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,535,064 | 37.615% | 3,388,478 | 1,688,886 | 1,013,805 | 630,592 | |
| Net Finance Costs / (Income) | (21,343) | 294.146% | (18,835) | (38,132) | (44,251) | (78,394) | |
| Depreciation & Amortisation | 500,955 | 50.831% | 703,098 | 459,037 | 335,951 | 143,770 | |
| Directors' Emoluments | -- | -- | 66,590 | 40,065 | 32,177 | 25,290 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 61.000 | -- | 81.000 | 43.000 | 27.000 | 17.333 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.822 | 0.476 | 0.325 | 0.210 |
| NBV per share ($) | 8.083 | -- | 7.579 | 5.034 | 3.292 | 2.173 |
| Remarks: | Real time quote last updated: 21/03/2023 13:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,535,064 |
| %Change | 37.615% |
| EPS / (LPS) | RMB 0.610 |
| NBV Per Share (¥) | RMB 8.083 |